Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07109518
What this trial is testing

UCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Study completedNCT04231747
What this trial is testing

CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma Non-HodgkinAgressive LymphomaDiffuse-large B-cell Lymphoma (DLBCL)
Juno Therapeutics, a Subsidiary of Celgene 24
Not applicableStudy completedNCT02666248
What this trial is testing

Long-term Follow-up of Subjects Exposed to Lentiviral-based CART-EGFRvIII Gene-modified Cellular Therapy Products in Cancer Studies

Who this might be right for
Subjects Entering Into This Protocol Will be Followed for up to 15 Years After Initial CART-EGFRvIII Infusion
University of Pennsylvania 3
Not applicableLooking for participantsNCT04914091
What this trial is testing

Quality Of Life and Drug Use in Patients With CAR-T Cells

Who this might be right for
Patients With Diffuse Large B-cell Lymphoma Treated With CART-cells
Hospices Civils de Lyon 70
Very early researchLooking for participantsNCT06307600
What this trial is testing

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

Who this might be right for
B Lymphoblastic Leukemia/Lymphoma
Anhui Provincial Hospital 9
Not applicableNot Yet RecruitingNCT06890091
What this trial is testing

Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma

Who this might be right for
Fatigue SymptomLymphoma Non-HodgkinChimeric Antigen Receptor T-cell Therapy+1 more
Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)Looking for participantsNCT06836505
What this trial is testing

Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.

Who this might be right for
Neuroblastoma (NB)Desmoplastic Small Round Cell Tumor (DSRCT)
Sun Yat-Sen University Cancer Center 10
Early research (Phase 1)Looking for participantsNCT07085676
What this trial is testing

Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

Who this might be right for
Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)Rheumatoid Arthritis (RA)+6 more
Polina Stepensky 120
Testing effectiveness (Phase 2)UnknownNCT04309981
What this trial is testing

Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody.

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Sara V. Latorre 73
Very early researchStudy completedNCT04652219
What this trial is testing

CART Therapy in GUCY2C-positive Digestive Tract Tumors

Who this might be right for
Malignant Neoplasms of Digestive Organs
Weijia Fang, MD 1
Not applicableLooking for participantsNCT06333275
What this trial is testing

Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy

Who this might be right for
Vaccine Immunity in CAR-T Cell Therapy Recipients
Insel Gruppe AG, University Hospital Bern 80
Not applicableLooking for participantsNCT07309497
What this trial is testing

Pragmatic Geriatric Assessment Before CAR-T or Bispecific Antibody Therapy to Predict Side Effects and Outcomes in Older Patients (GA-ACT Trial)

Who this might be right for
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaCART TherapyBispecific Antibody+1 more
University of Zurich 208
Early research (Phase 1)Looking for participantsNCT07541391
What this trial is testing

Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Peter MacCallum Cancer Centre, Australia 12
Testing effectiveness (Phase 2)Looking for participantsNCT06947460
What this trial is testing

CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH

Who this might be right for
Refractory Lupus NephritisSystemic SclerosisPrimary Sjogren's Syndrome Combined With Pulmonary Hypertension+1 more
Beijing GoBroad Hospital 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT06084884
What this trial is testing

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 94
Large-scale testing (Phase 3)Looking for participantsNCT07391657
What this trial is testing

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

Who this might be right for
Relapsed Refractory Multiple Myeloma
AstraZeneca 508
Very early researchUnknownNCT04173988
What this trial is testing

Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
ALL, Childhood B-Cell
Children's Hospital of Fudan University 6
Early research (Phase 1)UnknownNCT03114670
What this trial is testing

Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT

Who this might be right for
Adult Acute Myeloid Leukemia
Affiliated Hospital to Academy of Military Medical Sciences 20
Not applicableUnknownNCT06160362
What this trial is testing

The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Henan Cancer Hospital 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT06038474
What this trial is testing

Descartes-08 for Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Cartesian Therapeutics 6
Next Page